كل ما تود معرفته عن BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023

A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier/File Photo

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through…

26 September 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021

Popular
Editor's Pick

Eduardo Ramon

Politics

Why siccing Syria's army on Hezbollah is so dangerous

28 June 2026

If Trump's idea is implemented, it would all but certainly further undermine regional stability and US interests in the Middle East

David Schenker

Neil Webb

Science & Technology

The G7 grapples with the politics of AI access

23 June 2026

As advanced AI models become strategic assets, the G7 is confronting difficult questions of access, dependence, and control

Marco Mossad

Massad Boulos, Trump's Middle East advisor, speaks at the Libya Energy and Economic Summit at the Tripoli International Conference Centre in Tripoli on 24 January, 2026.

MAHMUD TURKIA / AFP

Politics

US plan for Libya: unification or management of division?

26 June 2026

A US envoy wants the institutions of western Libya to accommodate the son of an eastern warlord as Libyan president. Is this another doomed effort to unite the feuding factions, or could it work?

Areig Elhag

Grace Russell

Business & Economy

The World Cup is helping boost the Arab hospitality sector

26 June 2026

Owing to time-zone differences, the tournament is creating a new spending cycle for cafés and restaurants in Arab cities

Mohamed Sharki

Culture & Social Affairs

Umberto Eco's 'Inventing the Enemy' as relevant as ever

22 June 2026

A forgotten lecture by the renowned Italian writer at the University of Bologna in 2008 traced the history of hatred through language, myth, and imagination, all of which still apply today

Antoine Jockey

Sections

Regions

More

LATEST ISSUE

BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

Why siccing Syria's army on Hezbollah is so dangerous

The G7 grapples with the politics of AI access

US plan for Libya: unification or management of division?

The World Cup is helping boost the Arab hospitality sector

Umberto Eco's 'Inventing the Enemy' as relevant as ever

OPINIONS

Libya and Sudan: power‑sharing, oil and gold

Why siccing Syria's army on Hezbollah is so dangerous

The World Cup is helping boost the Arab hospitality sector

Scorching heat waves sweep Europe

BioNTech

Sign up for the Weekly Newsletter